Cargando…
IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients
OBJECTIVE: To describe the phenotypes, treatment response, and outcome of IgLON5 autoimmunity. METHODS: Archived serum and CSF specimens from 367 patients known to harbor unclassified antibodies which stained neural synapses diffusely (mimicking amphiphysin-IgG) were reevaluated by indirect immunofl...
Autores principales: | Honorat, Josephe A., Komorowski, Lars, Josephs, Keith A., Fechner, Kai, St Louis, Erik K., Hinson, Shannon R., Lederer, Sabine, Kumar, Neeraj, Gadoth, Avi, Lennon, Vanda A., Pittock, Sean J., McKeon, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515599/ https://www.ncbi.nlm.nih.gov/pubmed/28761904 http://dx.doi.org/10.1212/NXI.0000000000000385 |
Ejemplares similares
-
ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association
por: Alfugham, Nora, et al.
Publicado: (2017) -
Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG
por: Honorat, Josephe A., et al.
Publicado: (2019) -
Subacute encephalitis with recovery in IgLON5 autoimmunity
por: Ramanan, Vijay K., et al.
Publicado: (2018) -
Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023)